NeuroFrontiers

It may be challenging for a family member to take a video on their cell phone while a patient is having a seizure. However, they have been deemed useful in helping physicians establish a history of seizures in epileptic patients. So should clinicians consider this as a reimbursable diagnostic tool? Joined by the physician who posed this question in a recent article for the journal Neurology Clinical Practice, Dr. Andrew Wilner speaks with Dr. Selim Benbadis, Professor of Neurology and the Director of the Comprehensive Epilepsy Program at the University of South Florida.

Spinal muscular atrophy (SMA) is a rapidly progressive disease, but current treatment options might help us slow its progression. Dr. Charles Turck explores these treatment options with Dr. John Brandsema from the Perelman School of Medicine at the University of Pennsylvania.

Collaborative care plays an important role in treating patients is spinal muscular dystrophy (SMA). To learn more about this, Dr. Andrew N. Wilner is joined by Drs. Vanessa Battista and Nassim Rad to share their insights on team structures and collaborative care for SMA.

Alzheimer’s disease is the most common form of dementia, and symptoms become more severe over time. In fact, it’s the leading cause of disability and poor health in older adults. And although there’s no cure, a new medication called lecanemab recently received accelerated approval by the US Food and Drug Administration. So what might this new development mean for the 6 million Americans living with this debilitating disease? Find out as Dr. Andrew Wilner speaks with fellow ReachMD host Dr. David Weisman, who’s also the Director of Clinical Research at Abington Neurological Associates.

Given the prevalence of spinal muscular atrophy (SMA), why are there so many barriers to care? To answer this question, Dr. Jennifer Kwon explores unmet patient needs, the role of disease-modifying therapy in treatment, and strategies to overcome obstacles to care.

Due to the nature of their work, first responders may be at a higher risk for developing posttraumatic stress disorder (PTSD). So how can clinicians help their front-line patients with PTSD? Dr. Andrew Wilner will discuss this with Dr. Marilyn Wooley, Clinical Psychologist who specializes in treating first responders and author of the book, How Heroes Heal: Stories of First Responders and the Journey from Posttraumatic Stress Injury to Posttraumatic Growth.

In hopes of learning more about how the brain changes due to aging in patients with childhood-onset epilepsy, a new study was funded that may suggest some interesting findings. So what do we need to know from the results of this study? To dive into this topic, Dr. Andrew Wilner is joined by Dr. Bruce Hermann, Emeritus Professor at the University of Wisconsin School of Medicine and Public Health, and Dr. Shlomo Shinnar, Professor Emeritus of Neurology and Pediatrics at Albert Einstein College of Medicine.

A recent five-year observational study aimed to determine the impact of individual autonomic domains that were associated with Parkinson’s disease. So what were the key findings of this study? Join Dr. Jerome Lisk as he welcomes Dr. Katherine Longardner, Assistant Professor of Neurosciences at UC San Diego Health, to discuss this trial in-depth.

Magnetic resonance imaging (MRI) is an important tool for diagnosing multiple sclerosis (MS) and has been part of the diagnostic criteria for more than 20 years. But potential challenges can arise when reading an MRI scan, which can lead to a misdiagnosis. That’s why Drs. Stephen Yeung and James Stankiewicz join Dr. Jason Freeman to share best practices for understanding MRI scans for more accurate MS diagnosis.

246866 10/22

Trace amine-associated receptor type 1 (TAAR1) is thought to be the most important receptor for treating neuropsychiatric disorders, and it could provide more benefits and medications to patients with these illnesses. To discover more, Dr. Charles Turck, is joined by Dr. Craig Chepke, Clinical Assistant Professor of Psychiatry at SUNY Upstate Medical University.